Skip to main content
OpenTrials
Completed

NCT Number: NCT04055103

Improving Quality Based on the Joint Registry

Test whether an intervention, consisting of frequently feedback of performance outcomes and education will improve patient care, expressed in better functional outcomes, fewer complications and more quality improving interventions.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Leiden University Medical Center

Leiden, South Holland, 2333 ZA, Netherlands

About this study

A randomized controlled trial will be conducted where hospitals will be randomized to an early versus late group, stratified by teaching status as this might influence the time available for quality improvement. Randomization will be done using a computer generated randomization table in a 1:1 ratio. During the study only orthopedic surgeons performing THA and TKA will receive monthly feedback by email.

The intervention will consist of the following components:

  • Monthly feedback of performance outcomes;
  • Education on how to use joint registry data for quality improvement;
  • Create awareness by sending monthly feedback about performance; education and by asking what improvement activities have been introduced;
  • Hospitals will be linked to hospital with opposite performance outcomes to exchange information and find areas for improvement.

During the trial, the investigators will conduct monthly measurement on intermediate outcomes showing whether the intervention reaches the target group (process evaluation). The following measurements will take place:

  • Knowledge among orthopaedic surgeons on their recent performance and how that relates to others;
  • Number of quality improvement activities undertaken with the aim to improve the quality of care;
  • Planned improvement activities (e.g. record review to figure out why performance is not as good as in other centers) together with who is responsible and by which time;
  • Number of people attending the meetings, number of times a specific account has accessed the LROI site to ensure that information has reached the target group;
  • Survey among orthopaedic surgeons at the end of the intervention period on knowledge learned and the extent to which they think this is sustainable in daily practice.

In addition, the investigators will compare the outcomes between the early and the late group to test the effectiveness of the intervention, using the appropriate regression techniques. In the second period the investigators will test the sustainability of this approach in daily practice by comparing the outcomes within the early group with the first period, and compare with the late group to test whether outcomes in the sustainability phase are similar as when actively supported.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All Dutch orthopedic clinics where hip- and knee replacement surgery is performed who agree to participate will be randomized.

Exclusion criteria

  • None

Treatment and study plan

Monthly feedback, education and linking hospitals

Other
  • Give monthly feedback from LROI-data (revision rate & patient reported outcome measures) as well as other outcomes from the participating hospital (length-of-stay, readmission and complications), combined with education on how to use this information for improvement. This will be send monthly by email to the intervention group. Further, hospitals with worse performance for a certain outcome will be linked to hospitals with good performance for this outcome.

Primary outcomes

  1. Survival (yes/no)

    Time frame: 1 year follow-up during trial

    Patient survival after HA/TKA surgery

  2. 1-year revision rate (%)

    Time frame: 1 year follow-up during trial

    Number of revisions performed within one year adjusted for patient characteristics

  3. Prolonged length-of stay (yes/no)

    Time frame: 1 year follow-up during trial

    Prolonged length-of-stay in the overall upper quartile

  4. Readmission (yes/no)

    Time frame: 1 year follow-up during trial

    Readmission within 30 days after discharge

  5. Number of Complications

    Time frame: 1 year follow-up during trial

    Number of complications

  6. Composite outcome measure (Textbook Outcome)

    Time frame: 1 year follow-up during trial

    Including: Survival; 1-year revision rate; Length-of-Stay and Readmission.

Secondary outcomes

  1. Number of Quality Improvement Initiatives

    Time frame: 1 year follow-up during trial

    Number of quality improvement Initiatives with the aim to improve the quality of care

Sponsors and collaborators

Lead sponsor

Leiden University Medical Center

Other

Registry information

Acronym: IQ Joint

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Aug 13, 2019
Registry last updated
Oct 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.